PIK3CA mutation is the most common gene mutation in cancer and is an independent risk factor for affecting the overall survival (OS) and progression‐free survival (PFS) in NSCLC patients.4, 17. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.